| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.006 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |